5-氯-3-碘吡啶-2-醇 | 188057-28-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 中文名称: 5-氯-3-碘吡啶-2-醇
• 英文名称: 5-chloro-3-iodopyridin-2-ol
• 英文别名: 5-Chloro-3-iodopyridin-2(1H)-one；5-chloro-3-iodo-1H-pyridin-2-one
• CAS: 188057-28-5
• 化学式: C₅H₃ClINO
• 分子量: 255.442
• InChiKey: DKIIUJUXHIPYFQ-UHFFFAOYSA-N

物化性质

• 沸点：
  295.6±40.0 °C(Predicted)
• 密度：
  2.20±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.2
• 重原子数：
  9
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  29.1
• 氢给体数：
  1
• 氢受体数：
  1

安全信息

• 危险等级：
  IRRITANT
• 危险性防范说明：
  P280,P305+P351+P338
• 危险性描述：
  H302
• 储存条件：
  室温下保存，避免光照并置于干燥密闭容器中。

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 5-Chloro-3-iodopyridin-2-ol
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 5-Chloro-3-iodopyridin-2-ol
CAS number: 188057-28-5

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels, refrigerated.

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C5H3ClINO
Molecular weight: 255.4

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen chloride, hydrogen Iodide.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  5-氯-3-碘吡啶-2-醇 在 copper(l) iodide 、 四(三苯基膦)钯 、 potassium carbonate 、 cesium fluoride 、 三溴氧磷 作用下， 以 1,4-二氧六环 、 水 、 甲苯 为溶剂， 反应 45.0h， 生成 依托考昔
  参考文献：
  名称：

  一种依托考昔及其对照品5-氯-3-(4-(甲基磺酰基)苯基)-2,3-联吡啶的制备工艺

  摘要：

  本发明公开了一种依托考昔及其对照品5‑氯‑3‑(4‑(甲基磺酰基)苯基)‑2,3‑联吡啶的制备工艺。以5‑氯‑2‑羟基吡啶为原料，经取代反应得5‑氯‑3‑碘吡啶‑2‑醇；5‑氯‑3‑碘吡啶‑2‑醇经偶联反应得5‑氯‑3‑(4‑(甲基磺酰基)苯基)吡啶‑2‑醇；5‑氯‑3‑(4‑(甲基磺酰基)苯基)吡啶‑2‑醇经取代反应得到2‑溴‑5‑氯‑3‑(4‑(甲基磺酰基)苯基)吡啶；2‑溴‑5‑氯‑3‑(4‑(甲基磺酰基)苯基)吡啶经偶联反应得得目标产物依托考昔或其对照品5‑氯‑3‑(4‑(甲基磺酰基)苯基)‑2,3‑联吡啶，总收率可达18％。此路线是一条新的用于合成依托考昔或其对照品5‑氯‑3‑(4‑(甲基磺酰基)苯基)‑2,3‑联吡啶的工艺,填补了国内依托考昔对照品5‑氯‑3‑(4‑(甲基磺酰基)苯基)‑2,3‑联吡啶合成方法的空白。

  公开号：

  CN106632002A
• 作为产物：
  描述：

  5-氯-2-羟基吡啶 在 dipotassium peroxodisulfate 、 cerium(III) nitrate hexahydrate 、 三氟乙酸 、 sodium iodide 作用下， 以 1,2-二氯乙烷 为溶剂， 反应 24.0h， 以46%的产率得到5-氯-3-碘吡啶-2-醇
  参考文献：
  名称：

  喹啉，喹诺酮类，吡啶酮，吡啶和尿嘧啶的区域选择性碘化

  摘要：

  已经开发出基于自由基的直接CH碘化方案，用于喹啉，喹诺酮，吡啶酮，吡啶和尿嘧啶。碘化以喹啉和喹诺酮类化合物的C3选择性方式发生。吡啶酮...

  DOI：

  10.1039/c5cc07799k

文献信息

• [EN] CYCLOPENTENE COMPOUNDS<br/>[FR] COMPOSES DE CYCLOPENTENE
  申请人：GLAXO GROUP LTD

  公开号：WO2005037793A1

  公开（公告）日：2005-04-28

  Compounds of formula (I) or a pharmaceutically acceptable derivative thereof: wherein A, B, Z, R1, R2a, R2b, R8, R9, and Rx are as defined in the specification, a process for the preparation of such compounds, pharmaceutical compositions comprising such compounds and the use of such compounds in medicine.

  式（I）的化合物或其药用可接受的衍生物：其中A、B、Z、R1、R2a、R2b、R8、R9和Rx如规范中定义的那样，一种制备这种化合物的方法，包含这种化合物的药物组合物以及这种化合物在医学中的用途。
• Furopyridine, thienopyridine pyrrolopyridine useful in controlling
  申请人：Abbott Laboratories

  公开号：US06001849A1

  公开（公告）日：1999-12-14

  Novel heterocyclic ether compounds having the formula: ##STR1## wherein A, m, R, X, Y.sup.1, Y.sup.2 and Y.sup.3 are specifically defined, which are useful in selectively controlling chemical synaptic transmission; therapeutically-effective pharmaceutical compositions thereof; and use of said compositions to selectively control synaptic transmission in mammals.

  具有以下式子的新异杂环醚化合物：##STR1## 其中A、m、R、X、Y.sup.1、Y.sup.2和Y.sup.3具有特定定义，可用于有选择地控制化学突触传递；其治疗有效的药物组合物；以及使用该组合物有选择地控制哺乳动物的突触传递。
• Cyclopentene compounds
  申请人：Giblin Gerard Martin Paul

  公开号：US20090227591A1

  公开（公告）日：2009-09-10

  Compounds of formula (I) or a pharmaceutically acceptable derivative thereof: wherein A, B, Z, R 1 , R 2a , R 2b , R 8 , R 9 , and R x are as defined in the specification, a process for the preparation of such compounds, pharmaceutical compositions comprising such compounds and the use of such compounds in medicine.

  化合物的式子（I）或其药学上可接受的衍生物： 其中A、B、Z、R1、R2a、R2b、R8、R9和Rx如规范中所定义，制备这种化合物的工艺，包含这种化合物的制药组合物以及这种化合物在医学上的用途。
• IMIDAZOPYRROLIDINONE COMPOUNDS
  申请人：Novartis AG

  公开号：EP3272754A1

  公开（公告）日：2018-01-24

  The invention relates to compounds of formula (I): as described herein, pharmaceutical preparations comprising such compounds, uses and methods of use for such compounds in the treatment of a disorder or a disease mediated by the activity of MDM2 and/or MDM4, and combinations comprising such compounds.

  本发明涉及式 (I) 化合物： 如本文所述、包含此类化合物的药物制剂、此类化合物在治疗由 MDM2 和/或 MDM4 活性介导的紊乱或疾病中的用途和使用方法，以及包含此类化合物的组合物。
• FUROPYRIDINE, THIENOPYRIDINE, PYRROLOPYRIDINE AND RELATED PYRIMIDINE, PYRIDAZINE AND TRIAZINE COMPOUNDS USEFUL IN CONTROLLING CHEMICAL SYNAPTIC TRANSMISSION
  申请人：Abbott Laboratories

  公开号：EP0842178B1

  公开（公告）日：2001-03-28